These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12418946)

  • 21. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of a pill box clinic to improve systolic blood pressure in veterans with uncontrolled hypertension taking 3 or more antihypertensive medications.
    Porter AK; Taylor SR; Yabut AH; Al-Achi A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):905-11. PubMed ID: 25166289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure.
    Asayama K; Ohkubo T; Metoki H; Obara T; Inoue R; Kikuya M; Thijs L; Staessen JA; Imai Y;
    Hypertens Res; 2012 Nov; 35(11):1102-10. PubMed ID: 22895063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
    Chobanian AV; Bakris GL; Black HR; Cushman WC; Green LA; Izzo JL; Jones DW; Materson BJ; Oparil S; Wright JT; Roccella EJ; ;
    Hypertension; 2003 Dec; 42(6):1206-52. PubMed ID: 14656957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
    Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C
    Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication.
    Jeffers BW; Robbins J; Bhambri R; Wajsbrot D
    Am J Ther; 2015; 22(5):322-41. PubMed ID: 25738570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in prevalence, awareness, treatment and control of high blood pressure in the Seychelles between 1989 and 2013.
    Heiniger S; Viswanathan B; Gedeon J; Paccaud F; Bovet P
    J Hypertens; 2017 Jul; 35(7):1465-1473. PubMed ID: 28319592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010.
    Gu Q; Burt VL; Dillon CF; Yoon S
    Circulation; 2012 Oct; 126(17):2105-14. PubMed ID: 23091084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2010 guidelines of the Taiwan Society of Cardiology for the management of hypertension.
    Chiang CE; Wang TD; Li YH; Lin TH; Chien KL; Yeh HI; Shyu KG; Tsai WC; Chao TH; Hwang JJ; Chiang FT; Chen JH;
    J Formos Med Assoc; 2010 Oct; 109(10):740-73. PubMed ID: 20970072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Jeffers BW; Robbins J; Bhambri R
    Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence, awareness, treatment and control of hypertension in the Palestinian population.
    Khdour MR; Hallak HO; Shaeen M; Jarab AS; Al-Shahed QN
    J Hum Hypertens; 2013 Oct; 27(10):623-8. PubMed ID: 23575447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine.
    Hyman DJ; Pavlik VN
    Arch Intern Med; 2000 Aug 14-28; 160(15):2281-6. PubMed ID: 10927724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure control among treated hypertensives in a tertiary health institution.
    Sani MU; Mijinyawa MS; Adamu B; Abdu A; Borodo MM
    Niger J Med; 2008; 17(3):270-4. PubMed ID: 18788251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.